Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
ChAdOx1 nCoV-19 (AZD1222) 疫苗在肯尼亚成人中的安全性和免疫原性:一项 1/2 期单盲随机对照试验
期刊:Wellcome Open Research
影响因子:
doi:10.12688/wellcomeopenres.19150.2
Hamaluba, Mainga; Sang, Samuel; Orindi, Benedict; Njau, Irene; Karanja, Henry; Kamau, Naomi; Gitonga, John N; Mugo, Daisy; Wright, Daniel; Nyagwange, James; Kutima, Bernadette; Omuoyo, Donwilliams; Mwatasa, Mwaganyuma; Ngetsa, Caroline; Agoti, Charles; Cheruiyot, Stanley; Nyaguara, Amek; Munene, Marianne; Mturi, Neema; Oloo, Elizaphan; Ochola-Oyier, Lynette; Mumba, Noni; Mauncho, Cynthia; Namayi, Roselyne; Davies, Alun; Tsofa, Benjamin; Nduati, Eunice W; Aliyan, Nadia; Kasera, Kadondi; Etyang, Anthony; Boyd, Amy; Hill, Adrian; Gilbert, Sarah; Douglas, Alexander; Pollard, Andrew; Bejon, Philip; Lambe, Teresa; Warimwe, George